Endurant Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Endurant Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-16,890	Closed	-$1.48M	–	76
2020 Q1	$1.48M	Sell	16,890 -12,820	-43%	-$1.36M	0.67%	33
2019 Q4	$3.11M	Buy	29,710 +12,580	+73%	+$1.41M	0.98%	29
2019 Q3	$1.97M	Sell	17,130 -1,080	-6%	-$164K	0.71%	26
2019 Q2	$3.14M	Buy	+18,210	New	+$3.15M	1.24%	31

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Endurant Capital Management's GWPH Position: Q2 2020 in Review

Endurant Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2020, closing a stake of 16,890 shares — an estimated $1.48M sold.

Endurant Capital Management first reported a position in GWPH in Q2 2019 and held it in 4 quarters. The position peaked at $3.14M in Q2 2019. 299 funds tracked by Wall St. Rank hold GWPH as of Q2 2020.

Endurant Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
Endurant Capital Management sold 16,890 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2020, an estimated $1.48M.
Endurant Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 4 quarters.
Endurant Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.14M in Q2 2019.
299 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2020.

Based on Endurant Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.